Gemzar plus platinum therapy showing improved survival of nearly 40 percent

Lilly Korea held a recent symposium on Gemzar (gemcitabin), a third-generation anticancer drug, at Hotel Shilla and 50 hematological specialists attended the symposium at home and abroad.

The following comprehensive results of 13 clinical studies on 4,500 patients with non-small cell lung cancer all over the world, which were presented to the recent WCLC meeting in Canada, were announced by ...